exRNAdisease

Entry Detail

---



General Information

Database ID: exR0728936 RNA Name: hsa-miR-320a-3p RNA Type: miRNA Chromosome: chr8 Starnd: - Coordinate: Start Site(bp): 22244975 End Site(bp): 22244996 External Links: hsa-miR-320a-3p

Disease Information

Disease Name: Prostate Cancer Disease Category: Cancers MeSH ID: D011471 Type: Neoplasms/Digestive System Neoplasms Alias: Prostatic Neoplasms//Prostate Neoplasms//Neoplasms, Prostate//Neoplasm, Prostate//Prostate Neoplasm//Neoplasms, Prostatic//Neoplasm, Prostatic//Prostatic Neoplasm//Prostate Cancer//Cancer, Prostate//Cancers, Prostate//Prostate Cancers//Cancer of the Prostate//Prostatic Cancer//Cancer, Prostatic//Cancers, Prostatic//Prostatic Cancers//Cancer of Prostate

Expression Detail

GEO ID: GSE54010 Description: miRNA expression profiles in the 19 candidate urines (prostate cancer, CaP, patients and non-cancer subjects with benign prostatic hyperplasia, BPH) Experimental Design: Cancer vs Control Case Disease Type: Prostate Cancer Case Disease SubType: Advanced Prostate Cancer Case Sample: Advanced Prostate Cancer Control Sample: Benign Prostatic Hyperplasia Number of Case: 7 Number of Control: 5 Number of Samples: 12

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand ACAP2 chr3 195274745 195443044 - ASB1 chr2 238426742 238452250 + BLCAP chr20 37492472 37527931 - BTAF1 chr10 91923770 92030325 + CGN chr1 151510510 151538692 + CKAP5 chr11 46743048 46846308 - CRTC3 chr15 90529923 90645345 + FJX1 chr11 35618460 35620865 + GMCL1 chr2 69829660 69881384 + GNAI2 chr3 50226292 50259362 + HECTD2 chr10 91409280 91514829 + HSP90AB1 chr6 44246166 44253888 + IGF2BP3 chr7 23310209 23470491 - MKI67 chr10 128096659 128126423 - NR4A2 chr2 156324437 156342348 - PFN1 chr17 4945652 4949061 - SGK1 chr6 134169246 134318112 - SIN3A chr15 75369379 75455842 - SRSF7 chr2 38743599 38751494 - TRIM14 chr9 98069275 98119222 - VMA21 chrX 151396515 151409364 + ZCCHC2 chr18 62523025 62587709 + CDK2AP1 chr12 123250112 123272334 - CTNNA1 chr5 138610967 138935034 + HLA-DRA chr6 32439878 32445046 + MIF chr22 23894383 23895227 + PCLAF chr15 64364304 64387687 - SLC5A3 chr21 34073578 34106260 + miRNA targets: NA circRNA targets: NA lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand AC002044.1 chr16 73014319 73014476 - AC016876.2 chr17 7581964 7584086 - AC092718.4 chr16 81030770 81031485 + AL022311.1 chr22 37876148 37895563 + AL162258.1 chr1 153626332 153634340 - DLEU1 chr13 50082169 50906856 + GAS5 chr1 173858559 173868882 - LINC00641 chr14 21200079 21206900 - MALAT1 chr11 65497688 65506516 + MIR3142HG chr5 160438594 160487426 + NEAT1 chr11 65422774 65445540 + NR2F2-AS1 chr15 96110040 96327361 - OIP5-AS1 chr15 41283990 41309737 + SNHG1 chr11 62851984 62855953 - SNHG12 chr1 28578538 28583132 - XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE54010 Sample Source: Urine Source Fraction: Urine Platform: GPL15159 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 1183 Sample treatment protocol: NA RNA Extract protocol: Total RNA was extracted using RecoverAllTM Total Nucleic Acid Isolation kit (Life Technologies, Carlsbad, CA). RNA library preparation protocol: 400 ng of total RNA was labeled with cyanine 3-pCp using the Agilent miRNA Complete Labeling kit and hybridized to the array according to the manufacturer's protocol.

Reference

PMID: NA Title: NA Author: NA Journal: NA Description: NA